Literature DB >> 14742232

Pharmacokinetics of DA-7867, a new oxazolidinone, after intravenous or oral administration to rats: intestinal first-pass effect.

Soo K Bae1, Won-Suk Chung, Eun J Kim, Jae K Rhee, Jong W Kwon, Won B Kim, Myung G Lee.   

Abstract

Pharmacokinetic parameters of DA-7867 were dose independent after both intravenous administration and oral administration (at doses of 1 to 20 mg/kg of body weight) to rats. After oral administration of DA-7867 to rats at a dose of 10 mg/kg, approximately 8.27% of oral dose was not absorbed from the gastrointestinal tract, F was 70.8%, and approximately 21.8% of the oral dose was eliminated by the intestine (intestinal first-pass effect).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14742232      PMCID: PMC321507          DOI: 10.1128/AAC.48.2.659-662.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Intestinal first-pass effect of bumetanide in rats.

Authors:  E J Kim; K S Han; M G Lee
Journal:  Int J Pharm       Date:  2000-01-25       Impact factor: 5.875

2.  Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect.

Authors:  Eun J Kim; Soo K Bae; Hee J Kim; Yoon G Kim; Sun-O Kim; Dong H Lee; Hong Lim; Myung G Lee
Journal:  J Pharm Sci       Date:  2003-05       Impact factor: 3.534

3.  Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.

Authors:  Mi H Lee; Soo K Bae; Eun J Kim; Yoon G Kim; Sun-O Kim; Dong H Lee; Hong Lim; Sung-E Yoo; Myung G Lee
Journal:  J Pharm Sci       Date:  2003-01       Impact factor: 3.534

4.  Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: gastrointestinal first-pass effect.

Authors:  Su Yeon Yu; Soo Kyung Bae; Eun Jung Kim; Yoon Gyoon Kim; Sun-Ok Kim; Dong Ha Lee; Hong Lim; Myung Gull Lee
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

5.  High-performance liquid chromatographic analysis of DA-7867, a new oxazolidinone, in human plasma and urine and in rat tissue homogenates.

Authors:  Soo Kyung Bae; Eun Jung Kim; Jong Won Kwon; Won Bae Kim; Myung Gull Lee
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-09-05       Impact factor: 3.205

6.  Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects.

Authors:  F B Eatman; W A Colburn; H G Boxenbaum; H N Posmanter; R E Weinfeld; R Ronfeld; L Weissman; J D Moore; M Gibaldi; S A Kaplan
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

Review 7.  Linezolid: an oxazolidinone antimicrobial agent.

Authors:  H B Fung; H L Kirschenbaum; B O Ojofeitimi
Journal:  Clin Ther       Date:  2001-03       Impact factor: 3.393

8.  Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.

Authors:  So Hee Kim; Myung Gull Lee
Journal:  Life Sci       Date:  2002-02-01       Impact factor: 5.037

Review 9.  Oxazolidinone antibiotics.

Authors:  D J Diekema; R N Jones
Journal:  Lancet       Date:  2001-12-08       Impact factor: 79.321

10.  Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.

Authors:  J Kim; E J Kim; K S Han; M S Chang; M G Lee
Journal:  J Pharm Pharmacol       Date:  1999-09       Impact factor: 3.765

View more
  4 in total

1.  Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.

Authors:  Jee H Shin; Ka Y Choi; Yu C Kim; Myung G Lee
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  In vitro and in vivo activities of DA-7867, a new oxazolidinone, against aerobic gram-positive bacteria.

Authors:  Eun Jeong Yoon; Yeong Woo Jo; Sung Hak Choi; Tae Ho Lee; Jae Keol Rhee; Moohi Yoo; Mi Ja Shim; Eung Chil Choi
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 3.  Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections.

Authors:  Olatz Urbina; Olivia Ferrández; Mercè Espona; Esther Salas; Irene Ferrández; Santiago Grau
Journal:  Drug Des Devel Ther       Date:  2013-04-03       Impact factor: 4.162

4.  Therapeutic effect of a novel oxazolidinone, DA-7867, in BALB/c mice infected with Nocardia brasiliensis.

Authors:  Lucio Vera-Cabrera; Alejandra Daw-Garza; Salvador Said-Fernández; Hector Gerardo Lozano-Garza; Noemi Waksman de Torres; Norma Cavazos Rocha; Jorge Ocampo-Candiani; Sung-Hak Choi; Oliverio Welsh
Journal:  PLoS Negl Trop Dis       Date:  2008-09-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.